114 related articles for article (PubMed ID: 7819537)
1. KN-62, an inhibitor of Ca2+/calmodulin kinase II, attenuates circadian responses to light.
Golombek DA; Ralph MR
Neuroreport; 1994 Aug; 5(13):1638-40. PubMed ID: 7819537
[TBL] [Abstract][Full Text] [Related]
2. Circadian responses to light: the calmodulin connection.
Golombek DA; Ralph MR
Neurosci Lett; 1995 Jun; 192(2):101-4. PubMed ID: 7675313
[TBL] [Abstract][Full Text] [Related]
3. Diurnal, circadian and photic regulation of calcium/calmodulin-dependent kinase II and neuronal nitric oxide synthase in the hamster suprachiasmatic nuclei.
Agostino PV; Ferreyra GA; Murad AD; Watanabe Y; Golombek DA
Neurochem Int; 2004 Jun; 44(8):617-25. PubMed ID: 15016477
[TBL] [Abstract][Full Text] [Related]
4. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
Tokumitsu H; Chijiwa T; Hagiwara M; Mizutani A; Terasawa M; Hidaka H
J Biol Chem; 1990 Mar; 265(8):4315-20. PubMed ID: 2155222
[TBL] [Abstract][Full Text] [Related]
5. Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma.
Williams CL; Phelps SH; Porter RA
Biochem Pharmacol; 1996 Mar; 51(5):707-15. PubMed ID: 8615909
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of voltage-gated Ca2+ channel activity in small cell lung carcinoma by the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperaz ine) .
Williams CL; Porter RA; Phelps SH
Biochem Pharmacol; 1995 Dec; 50(12):1979-85. PubMed ID: 8849323
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of voltage-gated Ca2+ channels and insulin secretion in HIT cells by the Ca2+/calmodulin-dependent protein kinase II inhibitor KN-62: comparison with antagonists of calmodulin and L-type Ca2+ channels.
Li G; Hidaka H; Wollheim CB
Mol Pharmacol; 1992 Sep; 42(3):489-8. PubMed ID: 1328847
[TBL] [Abstract][Full Text] [Related]
8. Ca(2+)/calmodulin-dependent protein kinase II inhibitor KN-62 inhibits adrenal medullary chromaffin cell functions independent of its action on the kinase.
Tsutsui M; Yanagihara N; Fukunaga K; Minami K; Nakashima Y; Kuroiwa A; Miyamoto E; Izumi F
J Neurochem; 1996 Jun; 66(6):2517-22. PubMed ID: 8632177
[TBL] [Abstract][Full Text] [Related]
9. KN-62, a specific Ca++/calmodulin-dependent protein kinase inhibitor, reversibly depresses the rate of beating of cultured fetal mouse cardiac myocytes.
Okazaki K; Ishikawa T; Inui M; Tada M; Goshima K; Okamoto T; Hidaka H
J Pharmacol Exp Ther; 1994 Sep; 270(3):1319-24. PubMed ID: 7932185
[TBL] [Abstract][Full Text] [Related]
10. The effect of KN-62, Ca2+/calmodulin dependent protein kinase II inhibitor on cell cycle.
Minami H; Inoue S; Hidaka H
Biochem Biophys Res Commun; 1994 Feb; 199(1):241-8. PubMed ID: 8123019
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic signalling in the rodent neonatal suprachiasmatic nucleus identifies a role for protein kinase A and mitogen-activated protein kinase in circadian entrainment.
Schurov IL; Hepworth TJ; Hastings MH
Eur J Neurosci; 2002 Jan; 15(2):223-32. PubMed ID: 11849290
[TBL] [Abstract][Full Text] [Related]
12. Involvement of calcium-calmodulin protein kinase but not mitogen-activated protein kinase in light-induced phase delays and Per gene expression in the suprachiasmatic nucleus of the hamster.
Yokota S; Yamamoto M; Moriya T; Akiyama M; Fukunaga K; Miyamoto E; Shibata S
J Neurochem; 2001 Apr; 77(2):618-27. PubMed ID: 11299324
[TBL] [Abstract][Full Text] [Related]
13. Phase delays to light and gastrin-releasing peptide require the protein kinase A pathway.
Sterniczuk R; Yamakawa GR; Pomeroy T; Antle MC
Neurosci Lett; 2014 Jan; 559():24-9. PubMed ID: 24287375
[TBL] [Abstract][Full Text] [Related]
14. The involvement of calmodulin and Ca2+/calmodulin-dependent protein kinase II in the circadian rhythms controlled by the suprachiasmatic nucleus.
Fukushima T; Shimazoe T; Shibata S; Watanabe A; Ono M; Hamada T; Watanabe S
Neurosci Lett; 1997 May; 227(1):45-8. PubMed ID: 9178855
[TBL] [Abstract][Full Text] [Related]
15. cGMP-dependent protein kinase inhibitors block light-induced phase advances of circadian rhythms in vivo.
Mathur A; Golombek DA; Ralph MR
Am J Physiol; 1996 May; 270(5 Pt 2):R1031-6. PubMed ID: 8928902
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of constant light on circadian clock resetting by photic and nonphotic stimuli in Syrian hamsters.
Landry GJ; Mistlberger RE
Brain Res; 2005 Oct; 1059(1):52-8. PubMed ID: 16169532
[TBL] [Abstract][Full Text] [Related]
17. KN-62, a calcium/calmodulin-dependent protein kinase II inhibitor, inhibits high potassium-stimulated prolactin secretion and intracellular calcium increases in anterior pituitary cells.
Cui ZJ; Hidaka H; Dannies PS
Biochim Biophys Acta; 1996 Feb; 1310(3):343-7. PubMed ID: 8599613
[TBL] [Abstract][Full Text] [Related]
18. Signaling pathways for antigen receptor-mediated induction of transcription factor CREB in B lymphocytes.
Xie H; Wang Z; Rothstein TL
Cell Immunol; 1996 May; 169(2):264-70. PubMed ID: 8620554
[TBL] [Abstract][Full Text] [Related]
19. A selective Ca2+/calmodulin-dependent protein kinase II inhibitor, KN-62, inhibits the enhanced phosphorylation and the activation of tyrosine hydroxylase by 56 mM K+ in rat pheochromocytoma PC12h cells.
Ishii A; Kiuchi K; Kobayashi R; Sumi M; Hidaka H; Nagatsu T
Biochem Biophys Res Commun; 1991 May; 176(3):1051-6. PubMed ID: 1674865
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic serotonin (1A) mixed agonists/antagonists elicit large-magnitude phase shifts in hamster circadian wheel-running rhythms.
Gannon RL
Neuroscience; 2003; 119(2):567-76. PubMed ID: 12770569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
